Bisimide compounds
US6162822A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Dec 28, 1998 |
| Grant date | Dec 19, 2000 |
| Priority date | — |
| Expiry date | Dec 28, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC09B57/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound of formula (I) ##STR1## in which: m, and n, which may be identical or different, represent 0 or 1, PA0 X and Y, which may be identical or different, represent hydrogen or halogen or alky, trihaloalkyl, alkoxy, hydroxyl, cyano, nitro, amino, alkylamino or dialkylamino, PA0 Z represent a linear or branched C.sub.4 to C.sub.12 alkylene chain in which one or more --CH.sub.2 -- are optionally replaced by any one of the following atoms or groups: --NR--, --O--, --S--, --SO--, --SO.sub.2 --, or --CONH--, or by a substituted or unsubstituted heterocylcic, PA0 A forms, with two adjacent carbon atoms of the phenyl ring, a phenyl, naphthyl or tetrahydronaphthyl ring or a heterocycle, ##STR2## and medicinal products containing the same are useful as anticancer agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.